Get started
Author

Liam Shiels

Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2014 · Sweta Rani, Claire Corcoran, et al. · Cancer Research · 48
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate
2017 · Alice C. O’Farrell, Rhys Evans, et al. · PLoS ONE · 30
Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models
2014 · M A Jarzabek, V Amberger-Murphy, et al. · British Journal of Cancer · 28
PDF
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
2020 · Alice C. O’Farrell, Monika A. Jarzabek, et al. · Cancers · 20
PDF
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
2019 · Anne-Marie Baird, David Easty, et al. · Frontiers in Endocrinology · 13
PDF
Enhancing survival of Demodex mites in vitro
2018 · L. Shiels, R. Foley, et al. · Journal of the European Academy of Dermatology and Venereology · 6
Evaluation of Demodex mite viability using motility and scattered light intensity
2019 · S. Gatault, R. Foley, et al. · Experimental and Applied Acarology · 5
PDF
A comparative analysis of preclinical computed tomography radiomics using cone-beam and micro-computed tomography scanners
2024 · Kathryn H. Brown, Brianna N. Kerr, et al. · Physics and Imaging in Radiation Oncology · 4
79 The RON (MST1R)/MSP pathway is a potential therapeutic target in malignant pleural mesothelioma
2014 · A.-M. Baird, K.J. O'Byrne, et al. · Lung Cancer · 3
1009 Demodex mites modulate skin inflammation: Potential role in rosacea
2018 · S. Gatault, R. Foley, et al. · Journal of Investigative Dermatology · 2
DREAMER-S: Deep leaRning-Enabled Attention-based Multiple-instance approaches with Explainable Representations for Spatial biology
2026 · M. Rifqi Rafsanjani, Alison Dooney, et al. · PLoS Computational Biology
PDF
2292: A comparative analysis of preclinical CT-based radiomics using cone beam- and micro-CT scanners
2024 · Bríanna Kerr, Kathryn Brown, et al. · Radiotherapy and Oncology
Abstract 1441: Establishing a novel clinically relevant disease model of glioblastoma
2024 · Kate Connor, Kieron White, et al. · Cancer Research
Exth-64. Establishing a Clinically Relevant Mouse Model of Mesenchymal Glioblastoma for Studying Tme Targeting Treatments
2023 · Kate Connor, Kieron White, et al. · Neuro-Oncology
PDF
Data from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S3 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S1 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S2 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Table 2 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Material & Suppl. Table S1 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S4 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S4 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S2 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Fig. S1 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Suppl Table 2 from Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors
2023 · Sweta Rani, Claire Corcoran, et al.
Works count: 48
Citation count: 159
H-index: 6
I10-index: 5
Year
Topic
Type